BioSpace
Director, HEOR Strategy, US Access Evidence Strategy and Execution
BioSpace, Mettawa, Illinois, United States
Company Description
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, and eye care, as well as products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit
www.abbvie.com . Follow us on
X ,
Facebook ,
Instagram ,
YouTube ,
LinkedIn , and
TikTok . Job Description
The Director, HEOR Strategy, US Access Evidence Strategy and Execution, is accountable for the development and execution of the Immunology Inflation Reduction Act (IRA) value & evidence strategy and frameworks, capabilities to support drug price negotiation program (DPNP) efforts between AbbVie and CMS for the Immunology portfolio. He or she will report to the Director, HEOR Strategy, Pan Immunology and Access Evidence Excellence. Responsibilities
Coordinate with IRA Navigation and Possibilities (NAP) Leads, Government Affairs, other Pan IMM team leads, and HEOR IMM leadership to evaluate immunology evidence strategies. Educate and embed IRA operational readiness into the IMM HEOR team to accelerate and optimize IRA engagement outcomes. Provide thought leadership to immunology R&D, MHI, and PCS leadership, and coordinate with Government Affairs to ensure understanding of IRA impacts on immunology access evidence strategy. Oversee the design and conduct of projects, and effectively communicate findings and strategic impact to internal and external audiences. Ensure project plans align with IMM access strategic plans and commercial interests, providing updates and sharing decisions. Deliver end-to-end HEOR book of work, from strategy development to content implementation. Maintain strong partnerships with all relevant HEOR COE functions to ensure comprehensive HEOR representation in cross-functional meetings. Engage with senior leaders across functions, demonstrating executive presence. Qualifications
Advanced degree in health economics or related discipline. Minimum of seven years' experience with a Masters, or five years with a PhD, including fellowship experience. Experience in US private/public payer settings is preferred. Proven leadership in a global, cross-functional environment, with ability to support global business strategy. Ability to navigate uncharted territories and complex governmental regulations. Creative problem-solving skills to manage project conflicts and resource constraints. Goal-oriented with a solutions-focused approach. Extensive knowledge of global regulatory, HTA, and PR&A landscape, and understanding of drug development functions. Skills to lead cross-functional teams, manage scientific personnel, and interact with senior management globally. Self-starter with a strong desire for project success.
#J-18808-Ljbffr
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, and eye care, as well as products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit
www.abbvie.com . Follow us on
X ,
Facebook ,
Instagram ,
YouTube ,
LinkedIn , and
TikTok . Job Description
The Director, HEOR Strategy, US Access Evidence Strategy and Execution, is accountable for the development and execution of the Immunology Inflation Reduction Act (IRA) value & evidence strategy and frameworks, capabilities to support drug price negotiation program (DPNP) efforts between AbbVie and CMS for the Immunology portfolio. He or she will report to the Director, HEOR Strategy, Pan Immunology and Access Evidence Excellence. Responsibilities
Coordinate with IRA Navigation and Possibilities (NAP) Leads, Government Affairs, other Pan IMM team leads, and HEOR IMM leadership to evaluate immunology evidence strategies. Educate and embed IRA operational readiness into the IMM HEOR team to accelerate and optimize IRA engagement outcomes. Provide thought leadership to immunology R&D, MHI, and PCS leadership, and coordinate with Government Affairs to ensure understanding of IRA impacts on immunology access evidence strategy. Oversee the design and conduct of projects, and effectively communicate findings and strategic impact to internal and external audiences. Ensure project plans align with IMM access strategic plans and commercial interests, providing updates and sharing decisions. Deliver end-to-end HEOR book of work, from strategy development to content implementation. Maintain strong partnerships with all relevant HEOR COE functions to ensure comprehensive HEOR representation in cross-functional meetings. Engage with senior leaders across functions, demonstrating executive presence. Qualifications
Advanced degree in health economics or related discipline. Minimum of seven years' experience with a Masters, or five years with a PhD, including fellowship experience. Experience in US private/public payer settings is preferred. Proven leadership in a global, cross-functional environment, with ability to support global business strategy. Ability to navigate uncharted territories and complex governmental regulations. Creative problem-solving skills to manage project conflicts and resource constraints. Goal-oriented with a solutions-focused approach. Extensive knowledge of global regulatory, HTA, and PR&A landscape, and understanding of drug development functions. Skills to lead cross-functional teams, manage scientific personnel, and interact with senior management globally. Self-starter with a strong desire for project success.
#J-18808-Ljbffr